.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
The Tablet is stocked at 261 licensed dispensaries across California, with the deepest coverage in Los Angeles, San Diego, Sacramento, San Jose, and San Francisco. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Capsules account for 100.0% of The Tablet’s mix in July 2026, with year-over-year sales up 59.8% alongside a month-over-month lift of 3.8%, while average price is down 19.2% YoY and the brand holds rank 8 in Capsules in California. The single-category focus paired with a 59.8% YoY gain and only a 3.8% MoM uptick implies momentum built earlier in the year that is now moderating, and rank 8 suggests headroom to gain share if pricing at $32.19 continues to trade elasticity for volume.
The 19.2% YoY price decline against a 59.8% YoY sales increase indicates price-led penetration rather than assortment expansion, and the 3.8% MoM growth with an 8th-place standing points to incremental gains constrained by premium-tier ceilings. This pattern implies The Tablet is positioning as a value-forward Capsules specialist in California, using price to capture wallet share within Capsules rather than diversifying into adjacent formats, which may cap upside unless mix broadens or rank advances from 8 to a top-5 slot.
Competitive Landscape
The Tablet sits at rank #8 in CA Capsules in July 2026, down 1 position year over year from #7, and flat versus three months ago at #7 to #8, while its peak of #7 in May 2026 indicates only a 1-rank ceiling so far; in contrast, Breez holds #1 after falling from #2 year over year and posting a -32.37% sales change, and Emerald Bay Extracts advanced from #5 to #2 on +40.61% sales, signaling that competitors are converting momentum into rank gains that The Tablet has not matched. With Level sliding from #1 to #4 alongside a -60.24% sales drop and Buddies rising from #6 to #5 on +29.21% sales, the middle tier is in flux while The Tablet’s -1 YoY rank change and inability to exceed #7 imply a stall pattern where maintaining share will require catalysts beyond baseline execution.
Notable Products
Indica High Dose Tablets 50-Pack (1000mg) posted the largest movement with a 15.0% month-over-month gain while holding rank 3, contrasting with Sativa High Dose Tablets 50-Pack (1000mg) down 7.6% at rank 2. Sativa Tablets 20-Pack (1000mg) retained rank 1 despite a 3.6% decline, and Indica Tablets 20-Pack (1000mg) slipped 7.8% at rank 4; four of the top five are Capsules SKUs, concentrating share in a single dosage form. The $44,683 taken by Sativa Tablets 20-Pack (1000mg) alongside rank stability suggests reliance on legacy leaders even as High Dose formats shift demand toward potency. The pattern implies The Tablet is tilting its commercial mix toward high-dose Capsules while managing mild erosion in standard-dose Sativa lines.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
